alpha-Pyrrolidinobutiophenone

α-Pyrrolidinobutiophenone (α-PBP) is a stimulant compound developed in the 1960s[2] which has been reported as a novel designer drug. It can be thought of as the homologue lying between the two better known drugs α-PPP and α-PVP.

alpha-Pyrrolidinobutiophenone
Legal status
Legal status
Identifiers
  • (RS)-1-Phenyl-2-(1-pyrrolidinyl)-1-butanone
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC14H19NO
Molar mass217.312 g·mol−1
3D model (JSmol)
  • C2CCCN2C(CC)C(=O)c1ccccc1
  • InChI=1S/C14H19NO/c1-2-13(15-10-6-7-11-15)14(16)12-8-4-3-5-9-12/h3-5,8-9,13H,2,6-7,10-11H2,1H3 ☒N
  • Key:GSESDIFGJCCBHN-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Legality

In the United States, it is a Schedule I controlled substance.[3]

Sweden's public health agency suggested to classify α-PBP as hazardous substance on November 10, 2014.[4]

As of October 2015 α-PBP is a controlled substance in China.[5]

See also

References

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.